Exact Sciences Corp (NAS:EXAS)
$ 54.495 -0.225 (-0.41%) Market Cap: 10.09 Bil Enterprise Value: 11.79 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 80/100

Exact Sciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 10:15PM GMT
Release Date Price: $75.82 (-4.48%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good afternoon. I'm Tycho Peterson from life science team. It's my pleasure to introduce our next company this afternoon, Exact Sciences. (Operator Instructions). And with that, I'll turn it over to Kevin.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Tycho, thank you for having us once again. We appreciate and thanks all who are listening. Exact Sciences has a big mission. Our mission is to eradicate suffering caused by cancer. And we want to make the earlier detection of cancer a routine part of medical care. We're going to talk today about how we are doing that. We're going to talk about our results from 2021 and our plans for beyond. Before we get into that, here's a safe harbor statement. We have a full safe harbor statement on our website. I will be making forward-looking projections. Also, before I get into the discussion here today, I tested positive for COVID last night. I'm feeling great. I have a bit of a stuffy nose,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot